Brought to you by:
U.S. study highlights racial and ethnic disparities in the placement of ‘overused’ IVC filters
A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest inferior vena cava (IVC) filter placement rate per 100,000 persons compared with white and Latino patients…
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and registry data shows
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores and a lower incidence of post-thrombotic syndrome (PTS) out to 12 months compared with treatment using anticoagulation,…
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical thrombectomy as superior to CDT for acute PE
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT) was superior to catheter-directed thrombolysis (CDT) in patients diagnosed with acute pulmonary embolism (PE). Junji Taukagoshi,…
Nitinol stents placed in iliac veins “not associated with prolonged back pain,” study finds
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated to stent type, diameter, length or covered vein territory. Chloe Snow (Greenbelt, USA) and colleagues share…
Consortium led by vascular surgeon-scientist secures $6.4 million funding to develop sustainable alternative to contrast CT imaging
The European Union Horizon Europe, with joint funding from UK Research Innovation, has awarded the NetZeroAICT Consortium €6 million ($6.4 million) in funding to develop a novel artificial intelligence (AI)-based computed tomography (CT) technology that has the potential to promote…
VAM 2024 pricing now available
Pricing information for the 2024 Vascular Annual Meeting (VAM 2024) is now available. The event, scheduled in Chicago from June 19–22, is promoted as the year’s premier educational event for all vascular professionals. Organizers urge prospective attendees to secure funding…
As temporal trends in hemodialysis access creation emerge, notion of AV fistula superiority comes under scrutiny
The 2024 Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 24–27) hears three separate talks—two scientific papers and one from an invited guest lecturer—that separately and from different angles checked the pulse of the arteriovenous fistula (AVF)-first era. Sandwiched…
Landmark BEST-CLI trial gains recognition as top cardiovascular advance in 2023
The American Heart Association (AHA) has named the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial one of the top cardiovascular advances of 2023. This study—led by vascular surgeons Alik Farber, MD, and Matthew…
AAA and complex repair: ‘We need more evidence,’ says UChicago chief
A randomized controlled trial (RCT) of open repair versus endovascular aneurysm repair (EVAR) for the treatment of abdominal aortic aneurysms (AAAs), as well as head-to-head trials for additional information on EVAR and complex repairs, are warranted. This was the main…
Trial assessing AI-powered tissue microsensor technology in PAD begins enrollment
Sensome has announced enrollment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was designated a breakthrough medical device for use in brain arteries by the Food and Drug Administration (FDA)…